0.6300USD-1.56%Mkt Cap: 152.01M USDP/E: 3.94Last update: 2026-05-26
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap152.01M USD
Enterprise Value115.51M USD
Revenue (TTM)255.61M USD
Gross Profit54.03M USD
Net Income (TTM)16.33M USD
Revenue/Share1.095 USD
Last Price0.6300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)3.94
P/E (Forward)-1.01
PEG—
EV/EBITDA2.53
EV/Revenue0.45
P/S0.64
P/B1.86
EPS (TTM)0.16
EPS (Forward)-0.67
52W Range
0.260064% of range0.8400
52W High0.8400 USD
52W Low0.2600 USD
Profitability
Gross Margin21.14%
Oper. Margin13.19%
EBITDA Margin17.85%
Profit Margin6.88%
ROE18.60%
ROA8.77%
Growth
Revenue Growth87.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.71M USD
CapEx (TTM)145.00K USD
FCF Margin-12.42%
FCF Yield-20.88%
Net Debt-48.82M USD
Net Debt/EBITDA-1.07
Balance Sheet
Debt/Equity0.10
Current Ratio1.71
Quick Ratio1.54
Book Value/Sh0.3650 USD
Cash/Share0.2520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 9, 2012
Pay DateFeb 14, 2018
Splits
Last Split1:11
Split DateFeb 14, 2018
Analyst Consensus
Rating—
Target (Mean)3.000 USD
Target Range2.000 USD – 4.000 USD
# Analysts2
Ownership
Shares Out.241.97M
Float238.99M
Insiders1.34%
Institutions0.05%
Short Interest
Short Ratio2.6d
Short % Float9.40%
Short % Out.9.28%
Shares Short21.17M
Short (prev mo.)14.35M
Technical
SMA 500.6886 (-8.5%)
SMA 2000.5100 (+23.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)451.25K
Avg Vol (10d)485.07K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—